One in 7 women experience depression during the prenatal and/or postpartum period.
Nonpharmacologic approaches are known to be as effective as pharmacologic therapies for …

Introduction: Despite advances in obstetric care, postpartum hemorrhage (PPH) is a leading
cause of maternal mortality worldwide. Prior reviews of studies published through 2016 …

Postpartum hemorrhage (PPH) is an obstetric emergency. It is one of the top five causes of
maternal mortality in both resource-abundant and resource-limited countries, although the …

OBJECTIVE: To examine whether using selective serotonin reuptake inhibitors and selective
serotonin–norepinephrine reuptake inhibitors in pregnancy is associated with an increased …

Objective Evaluate whether selective serotonin reuptake inhibitor (SSRI) use during
pregnancy, as well as prior or current untreated psychiatric illness is associated with …

Background Delivery methods are associated with postpartum hemorrhage (PPH) both in
nulliparous and multiparous women. However, few studies have examined the difference in …

Background: Previous studies suggest an association between late pregnancy exposure to
selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake …

Evidence about relationship between antidepressant use during pregnancy and the risk of
postpartum hemorrhage (PPH) is conflicting. The aim of this meta-analysis was to …

Perinatal depression is associated with a high risk of morbidity and mortality and may have
long-term consequences on child development. The US Preventive Services Task Force has …

Background Antidepressant use later in pregnancy has been associated with preeclampsia
and postpartum haemorrhage (PPH) in some studies. Objectives To evaluate the …